Recent news on Trandolapril

Some hypertension drugs may help reduce dementia risk  -  May 7, 2007
Xinhua,Centrally acting drugs include captropril, fosinopril, lisinopril, perindopril, ramipril and trandolapril. The study found a link between taking centrally

Dementia Risk May Be Reduced By Some Hypertension Drugs  -  May 10, 2007
Medical News Today (press release),...captropril (Capoten®), fosinopril (Monopril®), lisinopril (Prinivil® or Zestri®), perindopril (Aceon®), ramipril (Altace®) and trandolapril (Mavik®).

Some heart drugs may slow mental decline with age  -  May 7, 2007
Scientific American...include captopril (Capoten), fosinopril (Monopril), lisinopril (Prinivil or Zestril), perindopril (Aceon), ramipril (Altace) and trandolapril (Mavik).

AGS: Centrally Active ACE Inhibitors May Slow Cognitive Decline  -  May 7, 2007
Psychiatric Times,Those agents are captopril (Capotel), fosinopril (Monopril), lisinopril (Prinivil or Zestril), perindopril (Aceon), ramipril (Altace) and trandolapril

Centrally active ACE inhibitors linked to lower rates of mental ...  -  May 7, 2007
TheHeart.Org,Solvay Pharmaceuticals), ramipril (Altace, King Pharmaceuticals), and trandolapril (Mavik, Abbott Laboratories), cross the blood-brain barrier.

Alzheimer's Risk Shielded by BP Drugs  -  May 7, 2007
The Money Times,The ACE inhibitor class includes drugs like captropril, fosinopril, lisinopril, perindopril, ramipril and trandolapril.

ACE Inhibitors Linked to Lower Rates of Mental Decline in Elderly  -  May 5, 2007
Medscape (subscription)...lisinopril (Prinivil or Zestril), perindopril (Aceon), ramipril (Altace), and trandolapril (Mavik), cross the blood-brain barrier.

CRP Levels Predict Events in Stable CHD Patients  -  27 Mar 2007
Medscape (subscription)3771 patients with stable coronary artery disease enrolled in the PEACE trial, a randomized placebo-controlled trial of the ACE inhibitor trandolapril.

CRP levels predict events in stable CHD patients  -  Mar 24, 2007
TheHeart.Org,3771 patients with stable coronary artery disease enrolled in the PEACE trial, a randomized placebo-controlled trial of the ACE inhibitor trandolapril.

New drug battles 'silent killer'  -  Mar 7, 2007
DrugResearcher.com,Many drugs in this class are already off patent and Abott's Mavik (trandolapril) is due off patent later this year with Solvay Pharmaceuticals'

Innovator's loss is the generic makers' gain  -  Feb 25, 2007
Express Pharma,It has also received ANDA approvals for Trandolapril tablets and Sertraline HCl tablets during the quarter. Biocon's Q3 FY07 registered a 26 percent growth

Lupin gets tentative US FDA approval for Trandolapril  -  Dec 19, 2006
Equity Bulls,The Company's Trandolapril Tablets will be the AR-rated generic equivalent of Abbott's Mavik® Tablets. Annual product sales in the US of the tablets were

Lupin Pharmaceuticals, Inc. Announces Tentative Approval Of ...  -  Dec 20, 2006
Medical News Today (press release),Upon final approval, Lupin's Trandolapril Tablets will be the AB-rated generic equivalent of Abbott's Mavik(R) Tablets, indicated for the treatment of

Buy Lupin; target of Rs 670: Sharekhan  -  Dec 20, 2006
Moneycontrol.com,Lupin has obtained a tentative approval from the US Food and Drug Authority (USFDA) for its abbreviated new drug application for Trandolapril tablets of

Lupin and Cornerstone BioPharma end development agreement  -  Dec 27, 2006
Myiris.com,Lupin recently received the US FDA tentative approval for the company`s abbreviated new drug application (ANDA) for Trandolapril tablets, 1mg, 2mg and 4mg.

Pharma Sector: Few Newsmakers Of The Week - Bristol-Myers, Glaxo ...  -  Dec 23, 2006
Trading Markets,Final approval for Lupin's trandolapril, the generic equivalent of Abbott's Mavik tablets, indicated for hypertension is expected, upon its patent

Lupin gets US FDA nod for Trandolapril  -  Dec 19, 2006
Financial Express,MUMBAI, DECEMBER 19: Pharmaceutical firm, Lupin said it has received USFDA tentative approval for Trandolapril tablets, used in the treatment of hypertension. ...

Lupin gets tentative US FDA approval for Trandolapril  -  Dec 19, 2006
Equity Bulls,19, 2006 has announced that the US FDA has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) for Trandolapril Tablets, 1mg ...

Lupin gets tentative US FDA approval for Trandolapril  -  Dec 18, 2006
Myiris.com,Lupin announced that the US FDA granted tentative approval for the company`s abbreviated new drug application (ANDA) for Trandolapril tablets, 1mg, 2mg and 4mg ...

Active Stock: Lupin advances marginally on FDA nod for ...  -  Dec 18, 2006
Myiris.com,The shares of Lupin are trading higher by 0.99% at BSE (10.37 am) on news of securing tentative approval from US FDA for Trandolapril tablets. ...

Lupin Pharmaceuticals, Inc. Announces Tentative Approval Of ...  -  Dec 20, 2006
Medical News Today (press release),...the US Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) for Trandolapril Tablets, 1mg ...

Pharma Sector: Few Newsmakers Of The Week - Bristol-Myers, Glaxo ...  -  Dec 23, 2006
Trading Markets,Chronic Hand Dermatitis. A Temporary Ease? Lupin's Hypertension Drug Trandolapril Gets Temporary FDA Approval. Lupin Pharmaceuticals Inc ...

Sun, Lupin to add two drugs in US market  -  Dec 19, 2006
Business Standard,Lupin’s Trandolapril Tablets will be the AB-rated generic equivalent of Abbott’s Mavik and enjoys annual product sales worth $ 53 million in the US. ...

Buy Lupin; target of Rs 670: Sharekhan  -  Dec 20, 2006
Moneycontrol.com,Lupin has obtained a tentative approval from the US Food and Drug Authority (USFDA) for its abbreviated new drug application for Trandolapril tablets of ...

Lupin gets tentative approval for its generic drug  -  Dec 19, 2006
Economic Times,MUMBAI: Mumbai-based Lupin Ltd said on Tuesday that the US FDA has granted tentative approval for the its generic hypertension drug Trandolapril Tablets, 1mg ...

Lupin gets tentative nod from FDA  -  Dec 19, 2006
BusinessWeekFinal approval of Lupin's Trandolapril tablets is expected when the patent protection of the brand product, Abbott Laboratories' Mavik tablets, expires on June ...

Lupin Gets Nod From FDA  -  Dec 19, 2006
Forbes,Final approval of Lupin's Trandolapril tablets is expected when the patent protection of the brand product, Abbott Laboratories (nyse: ABT - news - people ...

Lupin gets tentative nod from FDA  -  Dec 19, 2006
Euro2day,Final approval of Lupin''s Trandolapril 1mg, 2mg and 4mg tablets is expected when the patent protection of the brand product, Abbott Laboratories'' Mavik ...

Sección internacional  -  Dec 19, 2006
Bolsamania.com,Circuit Court ... [+. PRN) - Lupin Pharmaceuticals, Inc. Announces Tentative Approval of Trandolapril Tablets ... [+. PRN) - Century ...

ACE inhibitors beneficial in type 2 diabetes  Nov 2, 2006
In the study of 1180 type 2 diabetic patients with hypertension, treatment with the ACE inhibitor trandolapril, or trandolapril combined with another BP ... -Scientific American Benefits of Candesartan added to ACE inhibitor in inhibition of ...  Sep 2, 2006
They were randomised to ACE inhibitor, either Benazepril ( Lotensin ) 2.5 to 10 mg daily or Trandolapril ( Mavik ) 2 to 4 mg daily, plus Candesartan ( 2 to 12 ... -Xagena.it

Fasting Glucose Increases in Older Adults With Hypertension ...  -  Nov 16, 2006
Medscape (subscription)However, the International Verapamil-Trandolapril Study showed that an atenolol-hydrochlorothiazide based strategy was as effective as the

Should all atherosclerosis patients be given an ACE inhibitor? ...  Aug 11, 2006
...heart disease but without a history of heart failure or left ventricular systolic dysfunction, the addition of the ACE inhibitor trandolapril failed to provide ... -TheHeart.Org

Updating European Guidelines for the Management of Hypertension  Jul 17, 2006
For example, in the International Verapamil SR-Trandolapril Study (INVEST) study in patients with hypertension and coronary artery disease (CAD), the outcome ... -Medscape (subscription)

PEACE: ACE inhibitor ups survival in well-managed patients with ...  Jun 26, 2006
Dallas, TX - A retrospective look at a randomized trial that had found no overall survival benefit from the ACE inhibitor trandolapril among patients with ... -TheHeart.Org

Advisory - Health Canada reminds women not to use ACE inhibitors ...  Jun 29, 2006
...sold under the brand names Inhibace and Novo-Cilazapril) - Benazepril HCI (sold under the brand names Lotensin and Apo-Benazepril) - Trandolapril (sold under ... -CNW Telbec (Communiqués de presse)

Study Identifies Kidney Trouble as Heart Risk  Jun 28, 2006
The PEACE trial used one ACE inhibitor, trandolapril (Mavik), but "given that there have been so many studies with ACE inhibitors showing similar findings for ... -Forbes

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional